These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 5520275

  • 1. [Use of elipten in Itsenko-Cushing disease (preliminary report)].
    Marova EI, Lemesheva SN.
    Probl Endokrinol (Mosk); 1970; 16(5):7-10. PubMed ID: 5520275
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical experiences with aminoglutethimide (Elipten), a new inhibitor of steroid biosynthesis in the adrenal gland].
    Horký K, Küchel O, Gregorová I, Jiránková J, Matys Z.
    Schweiz Med Wochenschr; 1968 Nov 23; 98(47):1843-51. PubMed ID: 4236505
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy of amino-glutethimide in the ectopic ACTH syndrome.
    Gorden P, Becker CE, Levey GS, Roth J.
    J Clin Endocrinol Metab; 1968 Jun 23; 28(6):921-3. PubMed ID: 4172920
    [No Abstract] [Full Text] [Related]

  • 4. [A case of Cushing's disease treated by aminoglutethimide].
    Thevenet M, Lumbroso P, Netter A.
    Ann Endocrinol (Paris); 1968 Jun 23; 29(3):346-50. PubMed ID: 4326387
    [No Abstract] [Full Text] [Related]

  • 5. Effect of aminoglutethimide and reserpine on the human pituitary-adrenal axis: remission of a case of Cushing's disease.
    Givens JR, Camacho A, Patterson P.
    Metabolism; 1970 Oct 23; 19(10):818-30. PubMed ID: 4918596
    [No Abstract] [Full Text] [Related]

  • 6. Fatty acid composition of the sterol ester fraction of human adrenal cortex in Cushingś syndrome and after treatment with aminoglutethimide.
    Raggatt PR, Engel LL, Symington T.
    Lipids; 1972 Jul 23; 7(7):474-82. PubMed ID: 5049143
    [No Abstract] [Full Text] [Related]

  • 7. Qualitative alterations in urinary 17-ketosteroid excretion during aminoglutethimide administration.
    Horký K, Küchel O, Gregorvá I, Stárka L.
    J Clin Endocrinol Metab; 1969 Feb 23; 29(2):297-9. PubMed ID: 4236926
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical and biological study of an inhibitor of adrenocortical hormone synthesis: aminoglutethinide].
    Philbert M, Laudat MH, Laudat P, Bricaire H.
    Ann Endocrinol (Paris); 1968 Feb 23; 29(2):189-210. PubMed ID: 4298418
    [No Abstract] [Full Text] [Related]

  • 9. Amino-glutethimide (elipten) in adenocortical carcinoma.
    Miranda-Zetterstrand N, Díaz-Bonet L, Pagán-Sáez H, Rosaly de Jirau W.
    Bol Asoc Med P R; 1968 Dec 23; 60(12):611-8. PubMed ID: 5253414
    [No Abstract] [Full Text] [Related]

  • 10. [Inhibitions of steroid biosynthesis in the adrenal gland by aminogluthetimide (Elipten CIBA) and its practical significance].
    Horký K, Küchel O, Gregorová I, Jiránková J, Matys Z.
    Vnitr Lek; 1969 May 23; 15(5):417-25. PubMed ID: 5792533
    [No Abstract] [Full Text] [Related]

  • 11. Effects of aminoglutethimide in a case of ectopic ACTH syndrome. Influence on steroid metabolism.
    McMillan M, Maisey MN.
    Acta Endocrinol (Copenh); 1970 Aug 23; 64(4):676-86. PubMed ID: 4318105
    [No Abstract] [Full Text] [Related]

  • 12. Evidence suggesting 11 beta-hydroxylase inhibition during aminoglutethimide administration.
    Faglia G, Gattinoni L, Travaglini P, Neri V, Acerbi L, Ambrosi B.
    Metabolism; 1971 Mar 23; 20(3):266-72. PubMed ID: 5546922
    [No Abstract] [Full Text] [Related]

  • 13. [Reduced excretion of total gonadotropins during use of Elipten in breast neoplasms].
    Eliubaeva GO, Sanchakova AV, Vishnevskiĭ AS, Dil'man VM.
    Vopr Onkol; 1972 Mar 23; 18(3):92-3. PubMed ID: 5017847
    [No Abstract] [Full Text] [Related]

  • 14. The treatment of congenital adrenal hyperplasia with aminoglutethimide.
    Hamilton W.
    Q J Med; 1971 Oct 23; 40(160):568-9. PubMed ID: 5157412
    [No Abstract] [Full Text] [Related]

  • 15. [A comparative evaluation of the functional state of the adrenal cortex in puberty-juvenile dyspituitarism and Itsenko-Cushing disease (second report)].
    Egart FM, Lemesheva SN, Goncharova VN.
    Probl Endokrinol (Mosk); 1973 Oct 23; 19(4):37-40. PubMed ID: 4788098
    [No Abstract] [Full Text] [Related]

  • 16. Fluctuating Cushing's syndrome, acute psychosis, aminoglutethimide therapy.
    Barnett IG, Nabarro JD, LeQuesne LP.
    Proc R Soc Med; 1970 Apr 23; 63(4):338-9. PubMed ID: 5441960
    [No Abstract] [Full Text] [Related]

  • 17. Effects of aminoglutethimide upon adrenal function and cortisol metabolism in Cushing's syndrome.
    Schteingart DE, Conn JW.
    J Clin Endocrinol Metab; 1967 Dec 23; 27(12):1657-66. PubMed ID: 6060954
    [No Abstract] [Full Text] [Related]

  • 18. [Effects of aminoglutethimide on cortisol secretion in Cushing's disease].
    Boyer J, Valette A, Latrabe J, Codaccioni JL.
    Ann Endocrinol (Paris); 1973 Dec 23; 34(5):519-26. PubMed ID: 4368116
    [No Abstract] [Full Text] [Related]

  • 19. Aminoglutethimide: a "side-effect" turned to therapeutic advantage.
    Hughss SW, Burley DM.
    Postgrad Med J; 1970 Jul 23; 46(537):409-16. PubMed ID: 4920933
    [Abstract] [Full Text] [Related]

  • 20. [Effect of metopyrone on the levels of ACTH and 11-HCS in the plasma and the excretion of individual 17-HCS and 17-KS in Itsenko-Cushing disease].
    Marova EI, Lemesheva SN, Makarovskaia EE, Fedoseeva GI, Starkova NT.
    Probl Endokrinol (Mosk); 1972 Jul 23; 18(3):7-12. PubMed ID: 4337678
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.